Bioptimus Breakthrough: $76M Boost for Universal AI Model
Deal News | Jan 14, 2025 | Andera Partners
Bioptimus, an innovative company pioneering AI foundation models for biology, has announced it reached a significant funding milestone of $76 million. The latest $41 million cash injection was led by Cathay Innovation, with participation from notable investors including Sofinnova Partners, Bpifrance, and Andera Partners. Since its initial seed round, Bioptimus has launched H-Optimus-0, the world’s largest foundation model for pathology, which outperformed other models in key benchmarks. The company's next target is to release a comprehensive multi-scale, multi-modal AI foundation model for biology by 2025. This model promises to revolutionize research across various industries by integrating data across multiple scales and modalities, offering unprecedented insights into biological complexity. Co-founder and CEO, Jean-Philippe Vert, emphasized that this breakthrough will allow for advanced understanding and simulation of biological processes, propelling discoveries in medicine and beyond.
Sectors
- Artificial Intelligence
- Biotechnology
- Healthcare & Pharmaceuticals
Geography
- Global – Bioptimus's AI models are intended for global application across industries, impacting research and innovation worldwide.
Industry
- Artificial Intelligence – The article focuses on Bioptimus's development of AI models, which are crucial for simulating complex biological processes.
- Biotechnology – Bioptimus's new AI model aims to revolutionize biological research, impacting biotech industries significantly.
- Healthcare & Pharmaceuticals – The AI models developed by Bioptimus assist in predicting disease outcomes and designing therapies, directly benefiting the healthcare sector.
Financials
- $76 million – Total funding milestone announced by Bioptimus.
- $41 million – Latest cash injection led by Cathay Innovation.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Bioptimus | Target company | Company | A pioneering AI foundation model company focused on biology. |
| Cathay Innovation | Leading Investor | Company | An investment firm leading the $41 million funding round for Bioptimus. |
| Sofinnova Partners | Investor | Company | A participant in the funding round for Bioptimus. |
| Bpifrance | Investor | Company | Participating investor through its Large Venture Fund in Bioptimus's funding. |
| Andera Partners | Investor | Company | A participating investor in Bioptimus's funding. |
| Hitachi Ventures | Investor | Company | A participating investor in Bioptimus's funding. |
| Boom Capital Ventures | Investor | Company | A participating investor in Bioptimus's funding. |
| Pomifer Capital | Investor | Company | A participating investor in Bioptimus's funding. |
| Sunrise | Investor | Company | A participating investor in Bioptimus's funding. |
| Emmanuel Cassimatis | Angel Investor | Person | An angel investor involved in Bioptimus's funding. |
| Thomas Wolf | Angel Investor | Person | An angel investor involved in Bioptimus's funding. |